Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lisa Vork

Showing results (11-20 of 31) with videos related to

Pageof 4
Sort By:
Journal of Psychosomatic Research|January 7, 2021
Symptom-network dynamics in irritable bowel syndrome with comorbid panic disorder using electronic momentary assessment: A randomized controlled trial of escitalopram vs. placeboDaniël Kreiter, Marjan Drukker, Zlatan Mujagic, et al.
Journal of Psychosomatic Research|October 10, 2020
Network approach of mood and functional gastrointestinal symptom dynamics in relation to childhood trauma in patients with irritable bowel syndrome and comorbid panic disorderMarjan Drukker, Jill C H Peters, Lisa Vork, et al.
JMIR Formative Research|November 25, 2021
Digital Instruments for Reporting of Gastrointestinal Symptoms in Clinical Trials: Comparison of End-of-Day Diaries Versus the Experience Sampling MethodAbraham B Beckers, Johanna T W Snijkers, Zsa Zsa R M Weerts, et al.
Neurogastroenterology and Motility|November 22, 2018
The Experience Sampling Method-Evaluation of treatment effect of escitalopram in IBS with comorbid panic disorderLisa Vork, Zlatan Mujagic, Marjan Drukker, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|February 2, 2023
The Socioeconomic Impact of Irritable Bowel Syndrome: An Analysis of Direct and Indirect Health Care CostsMichelle H M A Bosman, Zsa Zsa R M Weerts, Johanna T W Snijkers, et al.
Neurogastroenterology and Motility|June 22, 2026
The Association Between Personality Traits and Irritable Bowel Syndrome-Insights From an Exploratory Cohort StudySylvester R Groen, Zsa Zsa R M Weerts, Lisa Vork, et al.
Autonomic Neuroscience : Basic & Clinical|March 29, 2025
Colonic mucosal TRPA1 expression profiles in irritable bowel syndrome and its correlation to symptom severity: An exploratory studySylvester R Groen, Daniel Keszthelyi, Ellen Wilms, et al.
Neurogastroenterology and Motility|May 24, 2019
Reduction in IBS symptom severity is not paralleled by improvement in quality of life in patients with irritable bowel syndromeZsa Zsa R M Weerts, Lisa Vork, Zlatan Mujagic, et al.
Advances in Therapy|October 5, 2018
A Novel Ileocolonic Release Peppermint Oil Capsule for Treatment of Irritable Bowel Syndrome: A Phase I Study in Healthy VolunteersZsa Zsa R M Weerts, Daniel Keszthelyi, Lisa Vork, et al.
JMIR Mhealth and Uhealth|October 8, 2020
Smart Data Collection for the Assessment of Treatment Effects in Irritable Bowel Syndrome: Observational StudyZsa Zsa R M Weerts, Koert G E Heinen, Ad A M Masclee, et al.
Pageof 4

Showing results (11-20 of 31) with videos related to

Sort By:
Pageof 4
Journal of Psychosomatic Research|January 7, 2021
Symptom-network dynamics in irritable bowel syndrome with comorbid panic disorder using electronic momentary assessment: A randomized controlled trial of escitalopram vs. placeboDaniël Kreiter, Marjan Drukker, Zlatan Mujagic, et al.
Journal of Psychosomatic Research|October 10, 2020
Network approach of mood and functional gastrointestinal symptom dynamics in relation to childhood trauma in patients with irritable bowel syndrome and comorbid panic disorderMarjan Drukker, Jill C H Peters, Lisa Vork, et al.
JMIR Formative Research|November 25, 2021
Digital Instruments for Reporting of Gastrointestinal Symptoms in Clinical Trials: Comparison of End-of-Day Diaries Versus the Experience Sampling MethodAbraham B Beckers, Johanna T W Snijkers, Zsa Zsa R M Weerts, et al.
Neurogastroenterology and Motility|November 22, 2018
The Experience Sampling Method-Evaluation of treatment effect of escitalopram in IBS with comorbid panic disorderLisa Vork, Zlatan Mujagic, Marjan Drukker, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|February 2, 2023
The Socioeconomic Impact of Irritable Bowel Syndrome: An Analysis of Direct and Indirect Health Care CostsMichelle H M A Bosman, Zsa Zsa R M Weerts, Johanna T W Snijkers, et al.
Neurogastroenterology and Motility|June 22, 2026
The Association Between Personality Traits and Irritable Bowel Syndrome-Insights From an Exploratory Cohort StudySylvester R Groen, Zsa Zsa R M Weerts, Lisa Vork, et al.
Autonomic Neuroscience : Basic & Clinical|March 29, 2025
Colonic mucosal TRPA1 expression profiles in irritable bowel syndrome and its correlation to symptom severity: An exploratory studySylvester R Groen, Daniel Keszthelyi, Ellen Wilms, et al.
Neurogastroenterology and Motility|May 24, 2019
Reduction in IBS symptom severity is not paralleled by improvement in quality of life in patients with irritable bowel syndromeZsa Zsa R M Weerts, Lisa Vork, Zlatan Mujagic, et al.
Advances in Therapy|October 5, 2018
A Novel Ileocolonic Release Peppermint Oil Capsule for Treatment of Irritable Bowel Syndrome: A Phase I Study in Healthy VolunteersZsa Zsa R M Weerts, Daniel Keszthelyi, Lisa Vork, et al.
JMIR Mhealth and Uhealth|October 8, 2020
Smart Data Collection for the Assessment of Treatment Effects in Irritable Bowel Syndrome: Observational StudyZsa Zsa R M Weerts, Koert G E Heinen, Ad A M Masclee, et al.
Pageof 4